Insights From the Use in Clinical Practice of Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome Affecting the Native Kidneys: An Analysis of 19 Cases

von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome

Miha Furlan, Rodolfo Robles, Miriam Galbusera et al. · New England Journal of Medicine · 1998 · 1.7K citations · Full text

Medicine, Hematology, Pathology +15

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

Christophe Legendre, Christoph Licht, Petra Muus et al. · New England Journal of Medicine · 2013 · 1.6K citations · Full text

Medicine, Hematology, Pharmacotherapy +17

VEGF Inhibition and Renal Thrombotic Microangiopathy

Vera Eremina, J. Ashley Jefferson, Jolanta Kowalewska et al. · New England Journal of Medicine · 2008 · 1.5K citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

Epidemic Profile of Shiga-Toxin–Producing<i>Escherichia coli</i>O104:H4 Outbreak in Germany

Christina Frank, Dirk Werber, Jakob P. Cramer et al. · New England Journal of Medicine · 2011 · 1.1K citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype

Marina Noris, Jessica Caprioli, Elena Bresin et al. · Clinical Journal of the American Society of Nephrology · 2010 · 1K citations · Full text

Life Sciences, Genetics, Human Genetics +13